Home-based Cognitive Monitoring in MCI

Phase

N/A

Condition

Dementia

Mild Cognitive Impairment

Memory Problems

Treatment

N/A

Clinical Study ID

NCT04350801

Hom-based cognitive monitoring

Ages > 50
All Genders

Study Summary

This study is an observational study to confirm usefulness of a home-based cognitive monitoring in non-demented patients with high-risk of dementia

Eligibility Criteria

Inclusion

Inclusion Criteria:

persistent cognitive complaints
aged 50 years old or older
below -1.0 standard deviation in any domain of detailed neuropsychological testsbattery named SNSB (Seoul neuropsychological screening battery)
no ADL (activities of daily living) limitation
subjects who agreed to participate

Exclusion

Exclusion Criteria:

dementia patients
other structural brain disorders such as hydrocephalus, hemorrhage, or tumors
other neurological disease such as Huntington's disease, Parkinson's disease, orepilepsy

Study Design

December 01, 2019

December 30, 2020

Study Description

We prospectively enroll subjects who were diagnosed as mild cognitive impairment based on neuropsychological tests battery, brain MRI, and routine blood labs including thyroid function tests, vitamine B12 & folate levels, and syphilis screening to rule out other secondary causes of dementia. We undergo peripheral blood-based amyloid beta levels and regular home-based cognitive monitoring (every 3 months) to investigate whether amyloid-positive MCIs progress rapidly using home-based cognitive monitoring during 6 months.

Connect with a study center

Uijeongbu St. Mary's hospital
Uijeongbu, 11765
Korea, Republic of
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.